Ausgabe 4/2022
Inhalt (27 Artikel)
A Review of the Clinical Effectiveness and Safety of Hybrid Cooperative Complexes in Intra-articular Viscosupplementation
Marcin Domżalski, Alberto Migliore
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
Shirley P. Huang, Sonya J. Snedecor, Sakina Nanji, Emily Lloyd, Christopher F. Bell
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
Atul Deodhar, Suleman Bhana, Kevin Winthrop, Lianne S. Gensler
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J. Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Sheng Gao, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie L. Xu, Frédéric Baribaud, Kristen Sweet
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Manuel José Moreno-Ramos, Carlos Sanchez-Piedra, Olga Martínez-González, Carlos Rodríguez-Lozano, Carolina Pérez-Garcia, Mercedes Freire, Cristina Campos, Rafael Cáliz-Caliz, Jerusalem Calvo, Juan María Blanco-Madrigal, Ana Pérez-Gómez, María José Moreno-Martínez, Luis Linares, Fernando Sánchez-Alonso, Carlos Sastré, Isabel Castrejón
Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis
Ting Cheng, Sheng-Xiao Zhang, Jia Wang, Jun Qiao, Min-Jing Chang, Hong-Qing Niu, Guang-Ying Liu, Xiao-Feng Li
Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study
Jove Graham, Tonia Novosat, Haiyan Sun, Brian J. Piper, Joseph A. Boscarino, Melissa S. Kern, Vanessa A. Hayduk, Eric A. Wright, Craig Beck, Rebecca L. Robinson, Edward Casey, Jerry Hall, Patricia Dorling
Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
Shan-Shan Li, Na Du, Shi-Hao He, Xu Liang, Tian-Fang Li
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs
Vardhaman Patel, Zulkarnain Pulungan, Anne Shah, Barton Jones, Allison Petrilla, Leticia Ferri, Xue Han, Kaleb Michaud
The Non-medical Switch from Reference Adalimumab to Biosimilar Adalimumab is Highly Successful in a Large Cohort of Patients with Stable Inflammatory Rheumatic Joint Diseases: A Real-Life Observational Study
Roxanne C. S. van Adrichem, Hanneke J. E. Voorneveld, Geeke J. Waverijn, Marc R. Kok, Radjesh J. Bisoendial
Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
Olivier Bruyère, Jean-Yves Reginster, Germain Honvo
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
Uta Kiltz, Petros P. Sfikakis, Karl Gaffney, Andreas Bounas, Nicola Gullick, Eric Lespessailles, Jan Brandt-Juergens, Rasho Rashkov, Barbara Schulz, Effie Pournara, Piotr Jagiello
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
Min Jung Kim, Sun-Kyung Lee, Sohee Oh, Hyoun-Ah Kim, Yong-Beom Park, Shin-Seok Lee, Kichul Shin
A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)
So-shin Ahn, Minkyung Lee, Yumin Baek, Sukho Lee
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study
Brigitte Michelsen, Kristine Thomassen Berget, Arthur Kavanaugh, Glenn Haugeberg
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
Philip Mease, Arthur Kavanaugh, Dafna Gladman, Oliver FitzGerald, Enrique R. Soriano, Peter Nash, Dai Feng, Apinya Lertratanakul, Kevin Douglas, Ralph Lippe, Laure Gossec
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Fabio Massimo Perrotta, Silvia Scriffignano, Francesco Ciccia, Ennio Lubrano
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study
Silvia Scriffignano, Fabio Massimo Perrotta, Mario di Marino, Francesco Ciccia, Ennio Lubrano
Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
Federico Boggio, Alessandro Ciavarella, Sara Arcudi, Roberta Gualtierotti, Raffaella Rossio, Francesco Tafuri, Andrea Artoni, Flora Peyvandi
Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
Mathieu Boudier-Revéret, Ming-Yen Hsiao, Min Cheol Chang
A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis
Salvatore Massimo Stella, Roberta Gualtierotti, Cesare Trentanni, Barbara Ciampi, Andrea Del Chiaro, Stefano Galletti
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
Josef Finsterer
A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
Alexandros A. Drosos, Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind
David Bernal-Bello, David Serantes-Gómez, Aida Izquierdo-Martínez, Alejandro Morales-Ortega, Miguel Ángel Duarte-Millán, Begoña Frutos-Pérez
A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind]
Bo Li, Junqing Yan, Jincheng Pu, Jianping Tang, Shuchang Xu, Xuan Wang
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study)
Blanca Hernández-Cruz, José Rosas, César Díaz-Torné, Joaquín Belzunegui, Rosario García-Vicuña, José Inciarte-Mundo, Ana Pons, Ana M. Millán, Sicylle Jeria-Navarro, Jesús A. Valero, Noelia García-Castañeda, Cristina Valero, Irene Llorente, Alberto Calvo, Silvia Díaz-Cerezo, Mercedes Núñez
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J. Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Sheng Gao, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie L. Xu, Frédéric Baribaud, Kristen Sweet